Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Glycopyrrolate 4 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design ensures a gradual release of the active ingredient, offering sustained therapeutic effects for conditions such as urinary incontinence, hyperhidrosis, chronic cough, gastroparesis, and bronchial asthma. The extended release profile reduces dosing frequency and improves patient compliance.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Glycopyrrolate 4 mg Slow Release Capsules is a compounded medication designed to treat a variety of conditions such as overactive bladder, urinary incontinence, and excessive sweating. This formulation is uniquely designed with Methocel E4M, a controlled-release polymer, to gradually release the active ingredient, glycopyrrolate, over an extended period of time. This slow and steady release mechanism offers sustained therapeutic effects, reduces dosing frequency, and improves patient compliance, particularly for medications requiring a controlled and prolonged release profile.
Glycopyrrolate functions by inhibiting the action of acetylcholine, a neurotransmitter responsible for controlling the muscles of the bladder and sweat glands. By blocking the action of acetylcholine, glycopyrrolate effectively reduces the symptoms associated with overactive bladder, urinary incontinence, and excessive sweating.
The recommended dosage of Glycopyrrolate 4 mg Slow Release Capsules is one capsule taken once daily. It is crucial to adhere to the prescribed dosage and not to exceed the recommended amount. Common side effects of this medication may include dry mouth, constipation, and blurred vision. However, the slow release formulation is designed to minimize these side effects and ensure a more comfortable patient experience.
If you have any questions or concerns about Glycopyrrolate 4 mg Slow Release Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the necessary information and support.
Glycopyrrolate 4 mg Slow Release Capsules are a compounded formulation designed to offer sustained therapeutic effects over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer that gradually releases the encapsulated medication. This formulation is designed to reduce dosing frequency and improve patient compliance, particularly for medications requiring a controlled and prolonged release profile.
These capsules may interact with other medications, including anticholinergics, antispasmodics, and antidiarrheals. It is crucial for patients to inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. Additionally, patients should disclose any allergies or medical conditions they may have. Glycopyrrolate 4 mg Slow Release Capsules should not be taken by patients who are pregnant or breastfeeding.
Glycopyrrolate 4 mg Slow Release Capsules are used to treat a variety of conditions, including overactive bladder, urinary incontinence, and irritable bowel syndrome. The medication works by blocking the action of acetylcholine, a chemical responsible for muscle contractions. This action helps to relax the muscles in the bladder and intestines, leading to improved bladder and bowel control.
Patients may experience side effects such as dry mouth, constipation, blurred vision, and dizziness. It is important for patients to contact their healthcare provider if they experience any of these side effects. Additionally, patients should reach out to their healthcare provider if they experience any other unusual symptoms while taking Glycopyrrolate 4 mg Slow Release Capsules.
If you have any questions about using Glycopyrrolate 4 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider for further information and guidance.
Glycopyrrolate 4 mg Slow Release Capsules are a specialized formulation designed to treat a range of conditions such as overactive bladder, urinary incontinence, and gastroesophageal reflux disease (GERD). The unique slow release formulation ensures a gradual release of the active ingredient, glycopyrrolate, into the body. This method of delivery not only minimizes the risk of side effects but also maintains a consistent level of the medication in the body, enhancing its efficacy.
The medication functions by inhibiting the action of acetylcholine, a chemical that stimulates the bladder muscles. This results in a reduction in the frequency of bladder contractions, thereby alleviating the symptoms of overactive bladder and urinary incontinence. Furthermore, glycopyrrolate can decrease the amount of acid produced in the stomach, which can help to mitigate the symptoms of GERD.
Glycopyrrolate 4 mg Slow Release Capsules should be consumed as per the instructions of your healthcare provider. The capsules are to be swallowed whole with a full glass of water. Consistency is key when taking this medication, it is crucial to take it at the same time each day to ensure a steady release of the medication into the body. Adequate hydration while on this medication is also important to minimize the risk of side effects.
If you have any queries regarding the functioning of Glycopyrrolate 4 mg Slow Release Capsules, do not hesitate to reach out. We are committed to helping you understand how this medication works and how it can effectively manage your condition.
Glycopyrrolate 4 mg Slow Release Capsules are a compounded formulation designed to gradually release the active ingredient over an extended period of time. This is achieved through the use of Methocel E4M, a controlled-release polymer. The slow release of the medication offers sustained therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
This formulation of Glycopyrrolate may be used to treat a variety of conditions. It is often used in the management of irritable bowel syndrome, peptic ulcer disease, and gastroesophageal reflux disease. In addition, it can be used to reduce the risk of aspiration during surgery, and to decrease the likelihood of aspiration pneumonia.
Patients with dysphagia, a condition that makes swallowing difficult, may also benefit from this formulation. This includes patients with dysphagia resulting from neurological disorders such as Parkinson's disease, stroke, or head and neck cancer. It may also be beneficial for patients with dysphagia due to laryngeal cancer.
If you have any questions about the use of Glycopyrrolate 4 mg Slow Release Capsules for any of these conditions, please do not hesitate to reach out for more information.
Glycopyrrolate 4 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the active ingredient over an extended period of time.
Methocel E4M is a type of controlled-release polymer. It is used in the formulation to ensure that the medication is released gradually over a prolonged period, offering sustained therapeutic effects.
A slow-release formulation offers several benefits. It provides sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, especially for medications that require a controlled and prolonged release profile.
The dosing frequency of Glycopyrrolate 4 mg Slow Release Capsules is typically less than that of regular medications due to its slow-release formulation. However, the exact frequency will depend on your doctor's prescription.
No, the slow-release formulation does not affect the effectiveness of the medication. In fact, it enhances the therapeutic effects by ensuring a steady release of the medication over an extended period.
No, you should not break or chew the capsules. Doing so can interfere with the controlled-release mechanism and may lead to a sudden release of a large amount of the medication, which can be harmful.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to catch up.
Yes, you can take Glycopyrrolate 4 mg Slow Release Capsules with or without food. However, it is important to take it at the same time each day to maintain a consistent level of medication in your body.
Like all medications, Glycopyrrolate 4 mg Slow Release Capsules can cause side effects. Common side effects may include dry mouth, blurred vision, and constipation. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
No, you should not stop taking Glycopyrrolate 4 mg Slow Release Capsules without consulting your healthcare provider, even if you feel better. Stopping the medication abruptly can lead to withdrawal symptoms or a relapse of your condition.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
